Symbol="PRQR"
AssetType="Common Stock"
Name="ProQR Therapeutics BV"
Description="ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands."
CIK="1612940"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="ZERNIKEDREEF 9, LEIDEN, NL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="125457000"
EBITDA="-49274000"
PERatio="None"
PEGRatio="0"
BookValue="0.64"
DividendPerShare="0"
DividendYield="0"
EPS="-0.75"
RevenuePerShareTTM="0.059"
ProfitMargin="0"
OperatingMarginTTM="-11.16"
ReturnOnAssetsTTM="-0.191"
ReturnOnEquityTTM="-0.782"
RevenueTTM="4482000"
GrossProfitTTM="4802000"
DilutedEPSTTM="-0.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.208"
AnalystTargetPrice="3.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.24"
PriceToBookRatio="1.702"
EVToRevenue="9.84"
EVToEBITDA="-0.502"
Beta="0.0003"
num_52WeekHigh="3.85"
num_52WeekLow="0.722"
num_50DayMovingAverage="1.618"
num_200DayMovingAverage="2.162"
SharesOutstanding="80940000"
DividendDate="None"
ExDividendDate="None"
symbol="PRQR"
open="1.54"
high="1.59"
low="1.54"
price="1.57"
volume="68733.00"
latest_trading_day="2023-08-28"
previous_close="1.55"
change="0.02"
change_percent="1.2903%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="335507"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.36"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_negative_thumbnail_id_2="98"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0078.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="524"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_positive_thumbnail_id_1="1008"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0170.jpeg"
image_positive_thumbnail_id_2="662"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
